Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pang, X
Protocols by Peter 1 disclosed protocol with verified dosing details
MEK blockade converts AML differentiating response to retinoic acid (RA) into extensive apoptosis: Involvement of Bcl-2 modulation and ROS accumulation
Rituximab, a monoclonal antibody targeting the CD20 antigen, depletes CD20-positive B lymphocytes through antibody-dependent cell-mediated cytotoxicity (ADCC), complement-mediated cytotoxicity (CDC), antibody-dependent cellular phagocytosis (ADCP), and programmed cell death (PD), providing a robust rationale for its use in treating SLE (114, 115)
US$ 22.67
US$ 26.77
US$ 24.34
US$ 28.26
US$ 28.32
US$ 25.19
US$ 20.98
US$ 23.01
US$ 25.43
US$ 22.98
